Short interest for Oncorus Inc rdinary Shares gives investors a sense of the degree to which investors are betting on the decline of Oncorus Inc rdinary Shares's stock. Short interest data is updated every two weeks.

Oncorus Inc rdinary Shares Stock (OTC:ONCR), Short Interest Report

Oncorus

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ARBK

BCEL

BFRI

CADL

CBIO

CJET

EVGN

EVLO

FFIE

GRCL

GREE

GRFX

GRNQ

IRNT

LITE

LMDX

MSGE

MULN

NAVB

NKLA

OCEA

ONCR

QURE

RVSN

SKIN

SQFT

TBLT

TCJH

TIVC

TLIS

VCIG

VEDU

VYGR

WORX

WRLD

Gainers


	Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares jumped 209.5% to $2.29 after the company signed a Letter of Intention with UAE-Based e-script medicine management company Pharmak Pharmacy.


Why ToughBuilt Industries Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

Pre-Market Outlook

ACLX

CANO

CYCC

DFLI

EBET

IDEX

INFI

REVB

Market Index Target Term Securities Linked To The Dow Jones Industrial Average

SRGA

VJET

Why Cano Health Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket

ADBE

ADRT

APPH

ATIP

AUVI

AXLA

CELZ

CHRS

CLNN

COHN

COMS

EDTX

FNGR

HCTI

HGEN

INVO

IRBT

JFBR

LEJU

LIDR

MBOT

Morgan Stanley Capital Protected Notes for S&P 500 Index

MVIS

NAAS

NBSE

NETI

OLMA

OPGN

OTRK

PBLA

PLTNR

Lordstown Motors Corp. - Class A Common Stock

RIDE

SPCE

SQSP

STXS

SURF

TNON

Gainers


	Oncorus, Inc. (NASDAQ: ONCR) shares surged 258% to $0.2781.


Why Squarespace Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

Oncorus Inc rdinary Shares

WIIM

Cinemark Holdings shares are trading higher after the company reported better-than-expected Q1 results.

Health Care

General

Zomedica Announced The Issuance Of Three New Patents Bolstering The Intellectual Property Protection For Its Revolutionary TRUFORMA Diagnostic Platform

Thomson Reuters (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRI#NYSE">TRI</a>) reported quarterly earnings of $1.11 per share which beat the analyst consensus estimate of $0.95 by 16.84 percent. This is a 32.14 percent increase over earnings of $0.84 per share from the same period last year. The company reported quarterly sales of $1.89 billion which beat the analyst consensus estimate of $1.86 billion by 1.34 percent. This is a 8.46 percent increase over sales of $1.74 billion the same period last year.

Earnings

Earnings Beats

Thomson Reuters Q1 Adj $1.11 Beats $0.95 Estimate, Sales $1.89B Beat $1.86B Estimate

Guidance

RXO Expects Q2 Adjusted EBITDA Of $24M-$30M; Sees Brokerage Gross Margin To Be Between 13%-15%

AULT

Ault Alliance Says Regained Compliance With NYSE American Continued Listing Standards

Needham analyst Bernie McTernan reiterates Zillow Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/Z#NASDAQ">Z</a>) with a Hold.

Reiteration

Analyst Ratings

Needham Reiterates Hold on Zillow Gr

BorgWarner Maintains FY24 Sales Guidance Of $14.4B-$14.9B (Est $14.758B), Raises Adjusted EPS Outlook From $3.65-$4.00 To $3.80-$4.15 (Est $3.90)

2024 Guidance
We now expect revenue growth of 9% to 12%, up 4% to 7% on an organic basis; operating margin of 16.9% to 17.5% and adjusted operating margin of 17.1% to 17.7%, up 20 to 80 bps (up 100 to 160 bps excluding the Svaneh&oslash;j acquisition dilution); full year EPS of $5.51 to $5.76 and adjusted EPS of $5.65 to $5.90, up 8% to 13% for the full year. We continue to expect free cash flow of $435 million to $475 million, representing 12% to 13% free cash flow margin for the full year.
It is not possible, without unreasonable efforts, to estimate the impacts of foreign currency fluctuations, acquisitions and certain other special items that may occur in 2024 as these items are inherently uncertain and difficult to predict. As a result, we are unable to quantify certain amounts that would be included in a reconciliation of organic revenue growth and adjusted segment operating margin to the most directly comparable GAAP financial measures without unreasonable efforts and accordingly we have not provided reconciliations for these forward-looking non-GAAP financial measures.

ITT Raises FY24 Adj. EPS Outlook To $5.65 - $5.90 9 (Up From $5.45 - $5.90) Vs. $5.79 Estimate, GAAP EPS $5.51 - $5.76 (Up From $5.37 - $5.82) Vs. $5.57 Estimate

Utz Brands Raised FY24 Adj. EPS Growth Outlook To 23%-28% (From 16%-21%)

Needham analyst Mike Cikos reiterates Tenable Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TENB#NASDAQ">TENB</a>) with a Buy and maintains $62 price target.

Price Target

TENB

Needham Reiterates Buy on Tenable Holdings, Maintains $62 Price Target

Biotech

MRNA

Moderna Reaffirms Its 2024 Expected Revenue Of Approximately $4B, Versus Consensus Of $4.21B From Its Respiratory Franchise, And Now Expects Approximately $0.3B In Net Sales In 1H 2024, Reflecting The Seasonality Of The Respiratory Business

2024&nbsp;Outlook
<ul>
<li>Total sales&nbsp;$3,040&nbsp;to&nbsp;$3,100&nbsp;million; Core sales growth +4 to&nbsp;6%</li>
</ul>
<ul>
<li>Adjusted operating profit margin expansion of 80 to 110 basis points year-over-year</li>
</ul>
<ul>
<li>Adjusted diluted net earnings per share in the range of&nbsp;$3.00&nbsp;to&nbsp;$3.15</li>
</ul>
<ul>
<li>Adjusted free cash flow conversion of ~90 to&nbsp;100%</li>
</ul>

Vontier Expects FY24 Sales of $3.040B-$3.100B Vs $3.096B Est, Reiterated Adj EPS of $3.00-$3.15 Vs $3.12 Est

Utz Brands Reiterated FY24 Organic Net Sales Growth Of ~3% Or Better, Adjusted EBITDA Growth Of 5% - 8%

RXO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RXO#NYSE">RXO</a>) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.04) by 25 percent. This is a 127.27 percent decrease over earnings of $0.11 per share from the same period last year. The company reported quarterly sales of $913.00 million which missed the analyst consensus estimate of $929.48 million by 1.77 percent. This is a 9.60 percent decrease over sales of $1.01 billion the same period last year.

Earnings Misses

RXO Q1 Adj $(0.03) Beats $(0.04) Estimate, Sales $913.00M Miss $929.48M Estimate

SWTX

Springworks' Cash, Cash Equivalents And Marketable Securities Were $573M As Of March 31, 2024

Needham analyst Ami Fadia reiterates Jazz Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAZZ#NASDAQ">JAZZ</a>) with a Buy and maintains $222 price target.

JAZZ

Needham Reiterates Buy on Jazz Pharmaceuticals, Maintains $222 Price Target

Teleflex Raises The Lower End Of FY24 Adj EPS Guidance From $13.55 - $13.95 To $13.60 - $13.95 Vs. $13.73 Est.

2024&nbsp;Outlook
<ul>
<li>Total sales&nbsp;$3,040&nbsp;to&nbsp;$3,100&nbsp;million; Core sales growth +4 to&nbsp;6%</li>
</ul>
<ul>
<li>Adjusted operating profit margin expansion of 80 to 110 basis points year-over-year</li>
</ul>
<ul>
<li>Adjusted diluted net earnings per share in the range of&nbsp;$3.00&nbsp;to&nbsp;$3.15</li>
</ul>
<ul>
<li>Adjusted free cash flow conversion of ~90 to&nbsp;100%</li>
</ul>
Q2&nbsp;2024&nbsp;Outlook
<ul>
<li>Total sales&nbsp;$735&nbsp;to&nbsp;$750 million; Core sales growth +2 to&nbsp;4%</li>
</ul>
<ul>
<li>Adjusted operating profit margin expansion of 20 to 60 basis points year-over-year</li>
</ul>
<ul>
<li>Adjusted diluted net earnings per share in the range of&nbsp;$0.67&nbsp;to&nbsp;$0.71</li>
</ul>

Vontier Expects Q2 Sales of $735M-$750M Vs $760.97M Est, Adj EPS of $0.67-$0.71 Vs $0.73 Est

CVNA

Carvana shares are trading higher after the company reported Q1 financial results.

Buybacks

BorgWarner Says Board Authorized An Additional Share Repurchase Program Of Up To $500Mn To Be Executed Over Next Three Years

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time for a look at the biggest pre-market stock movers traders need to keep an eye on for Tuesday!
Moving pre-market stock movers today is heavy trading, an earnings report, and a stock offering.
Let&rsquo;s get into this news below!

<h2>Pre-Market Stock Movers: 10 Top Gainers</h2>
<ol>
<li>QualTek Services (NASDAQ:<a href="https://investorplace.com/stock-quotes/qtek-stock-quote/">QTEK</a>) stock is rocketing 191% alongside incredibly heavy trading this morning.</li>
<li>Ideanomics (NASDAQ:<a href="https://investorplace.com/stock-quotes/idex-stock-quote/">IDEX</a>) shares are soaring more than 40% as it also sees extremely heavy trading Tuesday morning.</li>
<li>Monogram Orthopaedics (NASDAQ:<a href="https://investorplace.com/stock-quotes/mgrm-stock-quote/">MGRM</a>) stock is surging over 37% without any clear news this morning.</li>
<li>Wearable Devices (NASDAQ:<a href="https://investorplace.com/stock-quotes/wlds-stock-quote/">WLDS</a>) shares are increasing more than 26% as it <a href="https://investorplace.com/2023/05/why-is-wearable-devices-wlds-stock-up-250/">continues a rally from last week</a>.</li>
<li>Atento (NYSE:<a href="https://investorplace.com/stock-quotes/atto-stock-quote/">ATTO</a>) stock is gaining over 25% without any obvious news this morning.</li>
<li>Renalytix (NASDAQ:<a href="https://investorplace.com/stock-quotes/rnlx-stock-quote/">RNLX</a>) shares are rising more than 24% without any news to report on Tuesday morning.</li>
<li>WeTrade (NASDAQ:<a href="https://investorplace.com/stock-quotes/wetg-stock-quote/">WETG</a>) stock is climbing over 24% today.</li>
<li>Gaotu Techedu (NYSE:<a href="https://investorplace.com/stock-quotes/gotu-stock-quote/">GOTU</a>) shares are heading close to 23% higher with the release of its earnings report for the <a href="https://www.marketscreener.com/quote/stock/GAOTU-TECHEDU-INC-59126471/news/Gaotu-Techedu-Announces-First-Quarter-of-2023-Unaudited-Financial-Results-43981890/">first quarter of 2023</a>.</li>
<li>Equitrans Midstream (NYSE:<a href="https://investorplace.com/stock-quotes/etrn-stock-quote/">ETRN</a>) stock is jumping more than 16% without any recent news.</li>
<li>Windtree Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/wint-stock-quote/">WINT</a>) shares are up 16% on Tuesday.</li>
</ol>

<h2>10 Top Losers</h2>
<ol>
<li>Tian Ruixiang (NASDAQ:<a href="https://investorplace.com/stock-quotes/tirx-stock-quote/">TIRX</a>) stock is diving over 15% despite a lack of news this morning.</li>
<li>IronNet (NYSE:<a href="https://investorplace.com/stock-quotes/irnt-stock-quote/">IRNT</a>) shares are tumbling more than 15% following a roughly 33% rally on Friday.</li>
<li>Presto Automation (NASDAQ:<a href="https://investorplace.com/stock-quotes/prst-stock-quote/">PRST</a>) stock is taking a 15% beating after rocketing more than 60% on Friday.</li>
<li>Appreciate (NASDAQ:<a href="https://investorplace.com/stock-quotes/sfr-stock-quote/">SFR</a>) shares are falling over 13% as it also experienced a rally during the prior day of trading.</li>
<li>TScan Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/tcrx-stock-quote/">TCRX</a>) stock is sliding more than 13% after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317527308&amp;type=PDF&amp;symbol=TCRX&amp;cdn=1cd267db7e07b4cd5b788b32e8bc3120&amp;companyName=TScan+Therapeutics+Inc.&amp;formType=424B5&amp;formDescription=Prospectus+%5BRule+424%28b%29%285%29%5D&amp;dateFiled=2023-05-30">announcing a stock offering</a>.</li>
<li>Rave Restaurant (NASDAQ:<a href="https://investorplace.com/stock-quotes/rave-stock-quote/">RAVE</a>) shares are decreasing over 12% on Tuesday morning.</li>
<li>Quhuo (NASDAQ:<a href="https://investorplace.com/stock-quotes/qh-stock-quote/">QH</a>) stock is dropping more than 12% on Tuesday.</li>
<li>SunCar Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/sda-stock-quote/">SDA</a>) shares are slipping almost 12% in early morning trading.</li>
<li>Enthusiast Gaming (NASDAQ:<a href="https://investorplace.com/stock-quotes/eglx-stock-quote/">EGLX</a>) stock is dipping over 11% in pre-market trading.</li>
<li>Oncorus (NASDAQ:<a href="https://investorplace.com/stock-quotes/oncr-stock-quote/">ONCR</a>) shares close out our pre-market stock movers down more than 10%.</li>
</ol>
On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
<ul>
<li>
						<a href="https://investorplace.com/2022/07/little-known-apple-project/?cid=MKT639809&amp;eid=MKT653131">Buy This $5 Stock BEFORE This Apple Project Goes Live</a>
					</li>
<li>
						<a href="https://investorplace.com/2022/06/this-could-be-the-best-deal-in-the-history-of-independent-investing-research/?cid=MKT638063&amp;eid=MKT644740">The Best $1 Investment You Can Make Today</a>
					</li>
<li>
						<a href="https://investorplace.com/2023/04/one-of-the-worlds-biggest-tech-breakthroughs-could-be-happening-in-americas-heartland/?cid=MKT714907&amp;eid=MKT731269">Wall Street Titan: Here&rsquo;s My #1 Stock for 2023</a>
					</li>
<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT513141">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
</ul>
<div>
<div>
<div></div>
<div></div>
</div>
</div>
The post <a href="https://investorplace.com/2023/05/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-may-30th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time for a dive into the biggest pre-market stock movers for Friday as we check out the winners and losers this morning!
Moving stocks today are earnings reports, collaborations, clinical trial data, and more.
Let&rsquo;s get into that below!

<h2>Pre-Market Stock Movers: 10 Top Gainers</h2>
<ol>
<li>Yunji (NASDAQ:<a href="https://investorplace.com/stock-quotes/yj-stock-quote/">YJ</a>) stock is rocketing more than 74% with the release of its <a href="https://www.nasdaq.com/press-release/yunji-announces-first-quarter-2023-unaudited-financial-results-2023-06-02">Q1 2023 earnings report</a>.</li>
<li>U Power (NASDAQ:<a href="https://investorplace.com/stock-quotes/ucar-stock-quote/">UCAR</a>) shares are soaring over 47% as it continues to rally <a href="https://finance.yahoo.com/news/u-power-limited-enters-framework-120000740.html">on strategic partnership news</a>.</li>
<li>Better Choice (NYSEMKT:<a href="https://investorplace.com/stock-quotes/bttr-stock-quote/">BTTR</a>) stock is surging more than 36% after <a href="https://www.nasdaq.com/press-release/better-choice-announces-implementation-of-re%3aamaze-ai-beta-chat-bot-a-godaddy-brand">adding an AI chat bot</a>.</li>
<li>LAVA Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/lvtx-stock-quote/">LVTX</a>) shares are rising over 31% after picking a <a href="https://ir.lavatherapeutics.com/news-releases/news-release-details/lava-therapeutics-announces-selection-janssen-lead-gamma-delta-t">lead candidate for clinical trials</a>.</li>
<li>MongoDB (NASDAQ:<a href="https://investorplace.com/stock-quotes/mdb-stock-quote/">MDB</a>) stock is increasing close to 27% after <a href="https://www.prnewswire.com/news-releases/mongodb-inc-announces-first-quarter-fiscal-2024-financial-results-301840651.html">releasing fiscal Q1 2024 earnings</a>.</li>
<li>Vivos Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/vvos-stock-quote/">VVOS</a>) shares are gaining more than 26% on Friday morning.</li>
<li>Connect Biopharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/cntb-stock-quote/">CNTB</a>) stock is heading over 21% higher alongside positive <a href="https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-long-term-data-maintenance">Phase 2 clinical trial results</a>.</li>
<li>Sigma Additive Solutions (NASDAQ:<a href="https://investorplace.com/stock-quotes/sasi-stock-quote/">SASI</a>) shares are jumping more than 18% on Friday.</li>
<li>Powerbridge Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/pbts-stock-quote/">PBTS</a>) stock is getting an over 17% boost today.</li>
<li>Lululemon Athletica (NASDAQ:<a href="https://investorplace.com/stock-quotes/lulu-stock-quote/">LULU</a>) shares are up nearly 15% after <a href="https://www.cnbc.com/2023/06/01/lululemon-lulu-earnings-q1-2023.html">reporting sales growth</a>.</li>
</ol>

<h2>10 Top Losers</h2>
<ol>
<li>Kiora Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/kprx-stock-quote/">KPRX</a>) stock is plummeting almost 37% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317535836&amp;type=PDF&amp;symbol=KPRX&amp;cdn=03d35f0420b86ebcbc0a88c55d12fdde&amp;companyName=Kiora+Pharmaceuticals+Inc.&amp;formType=S-1%2FA&amp;formDescription=%5BAmend%5D+General+form+for+registration+of+securities+under+the+Securities+Act+of+1933&amp;dateFiled=2023-06-01">alongside a share offering</a>.</li>
<li>SentinelOne (NYSE:<a href="https://investorplace.com/stock-quotes/s-stock-quote/">S</a>) shares are diving close to 37% with <a href="https://finance.yahoo.com/news/sentinelone-announces-first-quarter-fiscal-201000666.html">a weak outlook</a> in its latest earnings report.</li>
<li>Oncorus (NASDAQ:<a href="https://investorplace.com/stock-quotes/oncr-stock-quote/">ONCR</a>) stock is tumbling more than 29% <a href="https://www.benzinga.com/pressreleases/23/06/g32680216/oncorus-announces-workforce-reduction-plan">after announcing layoffs</a>.</li>
<li>Trxade Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/meds-stock-quote/">MEDS</a>) shares are taking a nearly 18% beating on Friday morning.</li>
<li>Tigo Energy (NASDAQ:<a href="https://investorplace.com/stock-quotes/tygo-stock-quote/">TYGO</a>) stock is dropping over 12% after rallying <a href="https://www.nasdaq.com/press-release/tigo-energy-delivers-data-driven-solar-fleet-management-for-the-energy-intelligence">on solar fleet data</a> yesterday.</li>
<li>Ascent Solar Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/asti-stock-quote/">ASTI</a>) shares are falling more than 11% today.</li>
<li>Wejo (NASDAQ:<a href="https://investorplace.com/stock-quotes/wejo-stock-quote/">WEJO</a>) stock is sliding over 10% today.</li>
<li>Nephros (NASDAQ:<a href="https://investorplace.com/stock-quotes/neph-stock-quote/">NEPH</a>) shares are slipping almost 10% after rallying on Thursday.</li>
<li>China Liberal Education (NASDAQ:<a href="https://investorplace.com/stock-quotes/cleu-stock-quote/">CLEU</a>) stock is dipping more than 9% after a rally yesterday.</li>
<li>Monopar Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/mnpr-stock-quote/">MNPR</a>) shares close out our pre-market stock movers down over 9% following a jump <a href="https://www.marketwatch.com/story/monopar-therapeutics-shares-rise-6-after-new-data-on-camsirubicin-433608b3">alongside new data yesterday</a>.</li>
</ol>
On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
<ul>
<li>
						<a href="https://investorplace.com/2022/07/little-known-apple-project/?cid=MKT639809&amp;eid=MKT739312">Buy This $5 Stock BEFORE This Apple Project Goes Live</a>
					</li>
<li>
						<a href="https://investorplace.com/2023/05/did-elon-musk-just-trigger-a-new-netscape-moment/?cid=MKT738510&amp;eid=MKT741575">Did Elon Musk Just Trigger a New Netscape Moment?</a>
					</li>
<li>
						<a href="https://investorplace.com/2022/06/this-could-be-the-best-deal-in-the-history-of-independent-investing-research/?cid=MKT638063&amp;eid=MKT739344">The $1 Investment You MUST Take Advantage of Right Now</a>
					</li>
<li>
						<a href="https://investorplace.com/2023/05/secret-income-blueprint-of-the-one-percent/?cid=MKT730394&amp;eid=MKT738955">The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors</a>
					</li>
</ul>
<div>
<div>
<div></div>
<div></div>
</div>
</div>
The post <a href="https://investorplace.com/2023/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-june-2nd/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Oncorus could file for bankruptcy as most employees laid off; down 43%

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
We&rsquo;re starting off the week with a breakdown of the biggest pre-market stock movers for Monday morning!
Moving stocks this morning are acquisition deals, merger plans, study results, delisting notices, and more news.
Let&rsquo;s get into that news down below!

<h2>Pre-Market Stock Movers: 10 Top Gainers</h2>
<ol>
<li>Auddia (NASDAQ:<a href="https://investorplace.com/stock-quotes/auud-stock-quote/">AUUD</a>) stock is rocketing more than 91% without any apparent news this morning.</li>
<li>Infobird (NASDAQ:<a href="https://investorplace.com/stock-quotes/ifbd-stock-quote/">IFBD</a>) shares are surging over 73% without any clear news this morning.</li>
<li>Chinook Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/kdny-stock-quote/">KDNY</a>) stock is soaring more than 66% <a href="https://investors.chinooktx.com/news-releases/news-release-details/chinook-therapeutics-enters-agreement-be-acquired-novartis-ag">alongside a $3.2 billion acquisition deal</a> with Novartis AG (NYSE:<a href="https://investorplace.com/stock-quotes/nvs-stock-quote/">NVS</a>).</li>
<li>DatChat (NASDAQ:<a href="https://investorplace.com/stock-quotes/dats-stock-quote/">DATS</a>) shares are gaining over 41%</li>
<li>Recruiter.Com (NASDAQ:<a href="https://investorplace.com/stock-quotes/rcrt-stock-quote/">RCRT</a>) stock is rising more than 33% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317554077&amp;type=PDF&amp;symbol=RCRT&amp;cdn=71649394d3efae2689cf4576b7c82efb&amp;companyName=Recruiter.com+Group+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2023-06-09">alongside an acquisition agreement</a>.</li>
<li>Micromobility.com (NASDAQ:<a href="https://investorplace.com/stock-quotes/mcom-stock-quote/">MCOM</a>) shares are increasing by over 23% after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317556016&amp;type=PDF&amp;symbol=MCOM&amp;cdn=52b21cd8bb4c1ca3ecf90b548fe92b2e&amp;companyName=micromobility.com+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2023-06-09">covering its merger plans</a>.</li>
<li>Mcloud Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/mcld-stock-quote/">MCLD</a>) stock is climbing more than 23% on Monday morning.</li>
<li>JE Cleantech (NASDAQ:<a href="https://investorplace.com/stock-quotes/jcse-stock-quote/">JCSE</a>) shares are getting an over 21% boost during pre-market trading today.</li>
<li>Pharvaris (NASDAQ:<a href="https://investorplace.com/stock-quotes/phvs-stock-quote/">PHVS</a>) stock is jumping more than 16% after releasing data from its <a href="https://www.globenewswire.com/en/news-release/2023/06/10/2685890/0/en/Data-of-Deucrictibant-for-the-On-Demand-Treatment-of-HAE-Attacks-Presented-at-the-EAACI-Congress-2023.html">Phase 2 study of PHVS416</a>.</li>
<li>Moxian (NASDAQ:<a href="https://investorplace.com/stock-quotes/moxc-stock-quote/">MOXC</a>) shares are up over 14% despite a <a href="https://www.nasdaq.com/press-release/moxian-receives-nasdaq-notification-regarding-minimum-bid-requirements-2023-06-07">recent Nasdaq delisting notice</a>.</li>
</ol>

<h2>10 Top Losers</h2>
<ol>
<li>Nova Lifestyle (NASDAQ:<a href="https://investorplace.com/stock-quotes/nvfy-stock-quote/">NVFY</a>) stock is plummeting more than 38% without any recent news to report.</li>
<li>Oncorus (NASDAQ:<a href="https://investorplace.com/stock-quotes/oncr-stock-quote/">ONCR</a>) shares are diving over 26% after revealing plans for its <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317557107&amp;type=PDF&amp;symbol=ONCR&amp;cdn=e12f44187f73393a424ccf9bdc492bcd&amp;companyName=Oncorus+Inc.&amp;formType=PRE+14A&amp;formDescription=Preliminary+proxy+statement+providing+notification+matters+to+be+brought+to+a+vote&amp;dateFiled=2023-06-12">upcoming shareholder meeting</a>.</li>
<li>Better Choice (NYSEMKT:<a href="https://investorplace.com/stock-quotes/bttr-stock-quote/">BTTR</a>) stock is falling more than 16% this morning.</li>
<li>Cyxtera Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/cyxt-stock-quote/">CYXT</a>) shares are taking an over 17% beating as it <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317555392&amp;type=PDF&amp;symbol=CYXT&amp;cdn=7be1699449a2595a9429fc193b98b154&amp;companyName=Cyxtera+Technologies+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2023-06-09">continues with its bankruptcy filing</a>.</li>
<li>Forza X1 (NASDAQ:<a href="https://investorplace.com/stock-quotes/frza-stock-quote/">FRZA</a>) stock is decreasing more than 12% despite <a href="https://ir.forzax1.com/news-events/press-releases/detail/36/forza-x1-receives-order-from-onewater-marine-indicating-its">revealing new order news</a>.</li>
<li>VirnetX (NYSE:<a href="https://investorplace.com/stock-quotes/vhc-stock-quote/">VHC</a>) shares are dropping over 13% after announcing <a href="https://virnetx.com/company/press/">plans to sell some of its products</a>.</li>
<li>Grom Social (NASDAQ:<a href="https://investorplace.com/stock-quotes/grom-stock-quote/">GROM</a>) stock is falling more than 14% following a Friday rally.</li>
<li>Yunji (NASDAQ:<a href="https://investorplace.com/stock-quotes/yj-stock-quote/">YJ</a>) shares are slipping over 12% after revealing plans for <a href="https://www.nasdaq.com/press-release/yunji-announces-plan-to-implement-ads-ratio-change-2023-06-12">an ADS ratio change</a>.</li>
<li>Biomx (NYSEMKT:<a href="https://investorplace.com/stock-quotes/phge-stock-quote/">PHGE</a>) stock is dipping more than 11% <a href="https://ir.biomx.com/news-events/press-releases/detail/90/nyse-american-initiates-delisting-proceedings-for-biomx">as delisting looms</a>.</li>
<li>Oncology Institute (NASDAQ:<a href="https://investorplace.com/stock-quotes/toi-stock-quote/">TOI</a>) shares close out our pre-market stock movers down over 7%.</li>
</ol>
On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
<ul>
<li>
						<a href="https://investorplace.com/2022/07/little-known-apple-project/?cid=MKT639809&amp;eid=MKT739310">Buy This $5 Stock BEFORE This Apple Project Goes Live</a>
					</li>
<li>
						<a href="https://investorplace.com/2023/04/one-of-the-worlds-biggest-tech-breakthroughs-could-be-happening-in-americas-heartland/?cid=MKT714907&amp;eid=MKT739331">Wall Street Titan: Here&rsquo;s My #1 Stock for 2023</a>
					</li>
<li>
						<a href="https://investorplace.com/2022/06/this-could-be-the-best-deal-in-the-history-of-independent-investing-research/?cid=MKT638063&amp;eid=MKT739342">The $1 Investment You MUST Take Advantage of Right Now</a>
					</li>
<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT739347">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
</ul>
<div>
<div>
<div></div>
<div></div>
</div>
</div>
The post <a href="https://investorplace.com/2023/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-june-12th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Oncorus (NASDAQ:<a href="https://investorplace.com/stock-quotes/oncr-stock-quote/">ONCR</a>) stock is taking a beating on Monday after revealing plans for <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317557107&amp;type=PDF&amp;symbol=ONCR&amp;cdn=e12f44187f73393a424ccf9bdc492bcd&amp;companyName=Oncorus+Inc.&amp;formType=PRE+14A&amp;formDescription=Preliminary+proxy+statement+providing+notification+matters+to+be+brought+to+a+vote&amp;dateFiled=2023-06-12">an upcoming special shareholder meeting</a>.
According to a filing with the Securities and Exchange Commission (SEC), Oncorus is seeking investor attendance at the meeting to vote on certain matters. That includes the company&rsquo;s liquidation and dissolution plan.
Oncorus says that approval would allow its Board of Directors to move forward with the liquidation of dissolution of the company. It also mentions that the Board came to this decision after weighing the company&rsquo;s current financial situation.
While Oncorus has reviewed the reason for the meeting, it hasn&rsquo;t set a time yet. Instead, its SEC filing simply states that the shareholder meeting is set to take place sometime this year. Investors will want to keep an ear out for the final time of the meeting.
<h2>What This Means For ONCR Stock</h2>
The idea of Oncorus planning to liquidate and dissolve its business is bad news for ONCR stock. If that plans goes into action, it would no doubt result in shares of ONCR no longer existing. That easily explains why the company&rsquo;s stock is falling this morning.
Likewise, this news has investors fleeing ONCR with more than 1 million shares changing hands as of this writing. For the record, the company&rsquo;s daily average trading volume is closer to 927,000 shares.
This also has ONCR stock falling 27.3% as of Monday morning.
Investors looking for more of the latest stock market news are in the right place!

InvestorPlace is home to all of the hottest stock market news traders need to know about on Monday! A few examples include why shares of Chinook Therapeutics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/kdny-stock-quote/">KDNY</a>) and Auddia&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/auud-stock-quote/">AUUD</a>) stock are rising, as well as the biggest pre-market stock movers this morning. You can find out more on these matters at the following links!
<h2>More Stock Market News For Monday</h2>
<ul>
<li><a href="https://investorplace.com/2023/06/why-is-chinook-therapeutics-kdny-stock-up-58-today/">Why Is Chinook Therapeutics (KDNY) Stock Up 58% Today?</a></li>
<li><a href="https://investorplace.com/2023/06/why-is-auddia-auud-stock-up-95-today/">Why Is Auddia (AUUD) Stock Up 95% Today?</a></li>
<li><a href="https://investorplace.com/2023/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-june-12th/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a></li>
</ul>
On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/">Publishing Guidelines</a>.
With only the rarest exceptions,&nbsp;InvestorPlace&nbsp;does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;<a href="https://investorplace.com/stock-types/penny-stocks/">penny stocks</a>&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;&nbsp;<a href="http://investorplace.com/">InvestorPlace.com</a>&rsquo;s&nbsp;writers disclose this fact and warn readers of the risks.&nbsp;
Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/">How to Profit Without Getting Scammed</a>
<h3>More From InvestorPlace</h3>
<ul>
<li>
						<a href="https://investorplace.com/2022/07/little-known-apple-project/?cid=MKT639809&amp;eid=MKT739310">Buy This $5 Stock BEFORE This Apple Project Goes Live</a>
					</li>
<li>
						<a href="https://investorplace.com/2023/04/one-of-the-worlds-biggest-tech-breakthroughs-could-be-happening-in-americas-heartland/?cid=MKT714907&amp;eid=MKT739331">Wall Street Titan: Here&rsquo;s My #1 Stock for 2023</a>
					</li>
<li>
						<a href="https://investorplace.com/2022/06/this-could-be-the-best-deal-in-the-history-of-independent-investing-research/?cid=MKT638063&amp;eid=MKT739342">The $1 Investment You MUST Take Advantage of Right Now</a>
					</li>
<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT739347">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
</ul>
<div>
<div>
<div></div>
<div></div>
</div>
</div>
The post <a href="https://investorplace.com/2023/06/why-is-oncorus-oncr-stock-down-27-today/">Why Is Oncorus (ONCR) Stock Down 27% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Oncorus (ONCR) Stock Down 27% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Cyxtera Technologies&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/cyxt-stock-quote/">CYXT</a>) stock is falling on Monday as the company continues with its bankruptcy filing.
Cyxtera Technologies announced its bankruptcy filing at the start of the prior week. This saw it and several of its direct subsidiaries seeking Chapter 11 relief. Following this, the company entered into a Senior Secured Superpriority Debtor-in-Possession Credit Agreement with a group of lenders.
With that agreement, Cyxtera Technologies is able to <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317555392&amp;type=PDF&amp;symbol=CYXT&amp;cdn=7be1699449a2595a9429fc193b98b154&amp;companyName=Cyxtera+Technologies+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2023-06-09">borrow up to $200 million</a>. The agreement also allows for an interim $54 million to be borrowed. It will use these funds for working capital and other general corporate purposes, as well as transactions related to the bankruptcy and borrowing agreement.
<h2>How This Affects CYXT Stock Today</h2>
Investors aren&rsquo;t happy about Cyxtera Technologies filing for bankruptcy in the first place. Today&rsquo;s extra news isn&rsquo;t helping matters, either, even though it contains details about its financing through the bankruptcy process.
As a result, shares of CYXT stock are seeing incredibly heavy trading today as investors sell their stakes. This has more than 7 million shares of the company&rsquo;s stock changing hands as of this writing. That&rsquo;s a massive jump from its daily average trading volume of about 4.8 million shares.
CYXT stock is down 18.8% as of Monday morning and is down 97.5% since the start of the year.
Investors looking for even more of the most recent stock market news will want to keep reading!

InvestorPlace is home to all of the hottest stock market coverage traders need to know about on Monday! That includes what&rsquo;s happening with shares of Nio&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/nio-stock-quote/">NIO</a>), Xpeng&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/xpev)-stock-quote/">XPEV</a>), and Oncorus&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/oncr-stock-quote/">ONCR</a>) stock today. You can catch up on all of this news at the links below!
<h2>More Stock Market News For Monday</h2>
<ul>
<li><a href="https://investorplace.com/2023/06/why-is-nio-stock-up-5-today-2/">Why Is NIO Stock Up 5% Today?</a></li>
<li><a href="https://investorplace.com/2023/06/there-are-25000-reasons-xpeng-xpev-stock-is-up-10-today/">There Are 25,000 Reasons Xpeng (XPEV) Stock Is Up 10% Today</a></li>
<li><a href="https://investorplace.com/2023/06/why-is-oncorus-oncr-stock-down-27-today/">Why Is Oncorus (ONCR) Stock Down 27% Today?</a></li>
</ul>
On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/">Publishing Guidelines</a>.
With only the rarest exceptions,&nbsp;InvestorPlace&nbsp;does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;<a href="https://investorplace.com/stock-types/penny-stocks/">penny stocks</a>&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;&nbsp;<a href="http://investorplace.com/">InvestorPlace.com</a>&rsquo;s&nbsp;writers disclose this fact and warn readers of the risks.&nbsp;
Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/">How to Profit Without Getting Scammed</a>
<h3>More From InvestorPlace</h3>
<ul>
<li>
						<a href="https://investorplace.com/2022/07/little-known-apple-project/?cid=MKT639809&amp;eid=MKT739310">Buy This $5 Stock BEFORE This Apple Project Goes Live</a>
					</li>
<li>
						<a href="https://investorplace.com/2023/04/one-of-the-worlds-biggest-tech-breakthroughs-could-be-happening-in-americas-heartland/?cid=MKT714907&amp;eid=MKT739331">Wall Street Titan: Here&rsquo;s My #1 Stock for 2023</a>
					</li>
<li>
						<a href="https://investorplace.com/2022/06/this-could-be-the-best-deal-in-the-history-of-independent-investing-research/?cid=MKT638063&amp;eid=MKT739342">The $1 Investment You MUST Take Advantage of Right Now</a>
					</li>
<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT739347">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
</ul>
<div>
<div>
<div></div>
<div></div>
</div>
</div>
The post <a href="https://investorplace.com/2023/06/why-is-cyxtera-technologies-cyxt-stock-down-19-today/">Why Is Cyxtera Technologies (CYXT) Stock Down 19% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Cyxtera Technologies (CYXT) Stock Down 19% Today?

Oncorus Inc (ONCR) stock is down -95.06% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserverâ€&#x2122;s proprietary ranking system, gives ONCR stock a score of  0 out of a possible 100. That rank is mainly influenced by a long-term technical score of 0. ONCR's rank also inclu

Oncorus Inc (ONCR) Stock  Falls -27.27% This Week: Is It a Good Pick?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time for another dive into the biggest pre-market stock movers as investors get ready to trade shares on Wednesday!
Moving stocks this morning are clinical trial data, public share offerings, an earnings report, and more.
Let&rsquo;s get into this news below!

<h2>Pre-Market Stock Movers: 10 Top Gainers</h2>
<ol>
<li>Cyxtera Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/cyxt-stock-quote/">CYXT</a>) stock is rocketing more than 113% <a href="https://investorplace.com/2023/06/why-is-cyxtera-technologies-cyxt-stock-down-19-today/">alongside its ongoing bankruptcy</a>.</li>
<li>WiSA Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/wisa-stock-quote/">WISA</a>) shares are surging close to 66% after it <a href="https://ir.wisatechnologies.com/news-events/press-releases/detail/229/wisa-technologies-begins-taking-pre-orders-for-wisa-e">started taking pre-orders</a> for its WiSA E development kits yesterday.</li>
<li>NightHawk Biosciences (NYSEMKT:<a href="https://investorplace.com/stock-quotes/nhwk-stock-quote/">NHWK</a>) stock is soaring over 36% with heavy pre-market trading.</li>
<li>Inventiva (NASDAQ:<a href="https://investorplace.com/stock-quotes/iva-stock-quote/">IVA</a>) shares are rising nearly 27% alongside positive results from <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317562058&amp;type=PDF&amp;symbol=IVA&amp;cdn=dfd9727156557b563b09a93c96300910&amp;companyName=Inventiva+S.A.&amp;formType=6-K&amp;formDescription=Report+of+foreign+private+issuer+pursuant+to+Rule+13a-16+or+15d-16+under+the+Securities+Exchange+Act+of+1934&amp;dateFiled=2023-06-14">a Phase II clinical trial</a>.</li>
<li>Oncorus (NASDAQ:<a href="https://investorplace.com/stock-quotes/oncr-stock-quote/">ONCR</a>) stock is gaining more than 23% with extremely heavy trading on Wednesday morning.</li>
<li>Agile Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/agrx-stock-quote/">AGRX</a>) shares are increasing over 19% after announcing a <a href="https://ir.agiletherapeutics.com/news-releases/news-release-details/agile-therapeutics-announces-new-agreement-vitacarer">new agreement with vitaCare</a>.</li>
<li>T2 Biosystems (NASDAQ:<a href="https://investorplace.com/stock-quotes/ttoo-stock-quote/">TTOO</a>) stock is heading more than 18% higher following <a href="https://investors.t2biosystems.com/static-files/0f73f744-af9d-4a8b-b55c-29cb6ce9b501">an update on shares owned</a> by John Markey.</li>
<li>Beamr Imaging (NASDAQ:<a href="https://investorplace.com/stock-quotes/bmr-stock-quote/">BMR</a>) shares are getting an over 16% boost without any obvious news this morning.</li>
<li>Kuke Music (NYSE:<a href="https://investorplace.com/stock-quotes/kuke-stock-quote/">KUKE</a>) stock is jumping more than 16% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317559524&amp;type=PDF&amp;symbol=KUKE&amp;cdn=df1832347668a16d21a3df2e112959fa&amp;companyName=Kuke+Music+Holding+Limited+American+Depositary+Shares+each+representing+one&amp;formType=6-K&amp;formDescription=Report+of+foreign+private+issuer+pursuant+to+Rule+13a-16+or+15d-16+under+the+Securities+Exchange+Act+of+1934&amp;dateFiled=2023-06-13">following a delisting notice</a>.</li>
<li>Better Choice (NYSEMKT:<a href="https://investorplace.com/stock-quotes/bttr-stock-quote/">BTTR</a>) shares are up over 14% without any recent news.</li>
</ol>

<h2>10 Top Losers</h2>
<ol>
<li>Eastside Distilling (NASDAQ:<a href="https://investorplace.com/stock-quotes/east-stock-quote/">EAST</a>) stock is plummeting 31% after announcing a plan to trade <a href="https://www.prnewswire.com/news-releases/eastside-distilling-inc-announces-positive-business-and-financial-updates-301849765.html">$6.2 million of its debt for equity</a>.</li>
<li>Cineverse (NASDAQ:<a href="https://investorplace.com/stock-quotes/cnvs-stock-quote/">CNVS</a>) shares are diving more than 28% after <a href="https://finance.yahoo.com/news/cineverse-announces-proposed-public-offering-201500755.html">announcing a proposed public offering</a>.</li>
<li>Advanced Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/ahi-stock-quote/">AHI</a>) stock is tumbling over 22% as shares continue recent negative movement.</li>
<li>Coeptis Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/coep-stock-quote/">COEP</a>) shares are taking more than 21% beating after <a href="https://www.nasdaq.com/press-release/coeptis-therapeutics-receives-approval-to-transfer-to-the-nasdaq-capital-market-2023">switching to the Nasdaq Capital Market</a> yesterday.</li>
<li>Tenon Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/tnon-stock-quote/">TNON</a>) stock is falling 21% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317561972&amp;type=PDF&amp;symbol=TNON&amp;cdn=24d9f34dd6d7abdb224a1bc5919a6221&amp;companyName=Tenon+Medical+Inc.&amp;formType=EFFECT&amp;formDescription=Notice+of+Effectiveness&amp;dateFiled=2023-06-13">alongside a public share offering</a>.</li>
<li>OLB Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/olb-stock-quote/">OLB</a>) shares are sliding almost 17% following a rally yesterday.</li>
<li>Wheeler Real Estate IT (NASDAQ:<a href="https://investorplace.com/stock-quotes/whlr-stock-quote/">WHLR</a>) stock is decreasing over 15% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317559541&amp;type=PDF&amp;symbol=WHLR&amp;cdn=9b2ddf723baa578c59802f2c664e6669&amp;companyName=Wheeler+Real+Estate+Investment+Trust+Inc.&amp;formType=SC+13D%2FA&amp;formDescription=%5BAmend%5D+General+statement+of+acquisition+of+beneficial+ownership&amp;dateFiled=2023-06-13">alongside activist investor activity</a>.</li>
<li>IperionX (NASDAQ:<a href="https://investorplace.com/stock-quotes/ipx-stock-quote/">IPX</a>) shares are dropping more than 15% after rallying yesterday on <a href="https://www.nasdaq.com/press-release/iperionx-to-produce-titanium-components-for-ford-motor-company-2023-06-13">a deal with Ford</a> (NYSE:<a href="https://investorplace.com/stock-quotes/f-stock-quote/">F</a>).</li>
<li>Iteris (NASDAQ:<a href="https://investorplace.com/stock-quotes/iti-stock-quote/">ITI</a>) stock is slipping over 12% with the release of its <a href="https://finance.yahoo.com/news/iteris-iti-reports-q4-loss-211503597.html">latest earnings report</a>.</li>
<li>Nemaura Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/nmrd-stock-quote/">NMRD</a>) shares close out our pre-market stock movers down more than 12%.</li>
</ol>
On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
<ul>
<li>
						<a href="https://investorplace.com/2022/07/little-known-apple-project/?cid=MKT639809&amp;eid=MKT739310">Buy This $5 Stock BEFORE This Apple Project Goes Live</a>
					</li>
<li>
						<a href="https://investorplace.com/2023/04/one-of-the-worlds-biggest-tech-breakthroughs-could-be-happening-in-americas-heartland/?cid=MKT714907&amp;eid=MKT739331">Wall Street Titan: Here&rsquo;s My #1 Stock for 2023</a>
					</li>
<li>
						<a href="https://investorplace.com/2022/06/this-could-be-the-best-deal-in-the-history-of-independent-investing-research/?cid=MKT638063&amp;eid=MKT739342">The $1 Investment You MUST Take Advantage of Right Now</a>
					</li>
<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT739347">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
</ul>
<div>
<div>
<div></div>
<div></div>
</div>
</div>
The post <a href="https://investorplace.com/2023/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-june-16th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Oncorus, Microbot top healthcare gainers; Panbela, Clene among losers

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
As this is the year&rsquo;s halfway point, it&rsquo;s time to look hard at your portfolio for stocks to sell.
Ask yourself what&rsquo;s working and what&rsquo;s not. Are your returns as high as they should be, or is something holding you back? Do you have stocks that you need to sell now?
I&rsquo;ve written lately about the best stocks you can have in your portfolio for the second half of 2023, but it&rsquo;s also good to look at the other side of the coin and assess what stocks to sell as the calendar flips to July.
As we did when looking at the stocks to buy, we&rsquo;ll use the Portfolio Grader to benchmark disappointing stocks that should be on your &ldquo;sell&rdquo; list today.
As a reminder, the Portfolio Grader uses an &ldquo;A&rdquo; through an &ldquo;F&rdquo; scale to grade every stock based on various factors. They include earnings growth, sales, buying momentum, analyst sentiment, dividend performance and more.
Here&rsquo;s hoping that your portfolio doesn&rsquo;t have any of these F-rated stocks. But if they do, consider these stocks to sell before the second half of 2023 gets rolling.


<h2>Mullen Automotive (MULN)</h2>
<div><img src="https://investorplace.com/wp-content/uploads/2023/01/muln1600-2-300x169.png" alt="In this photo illustration, the Mullen Technologies (MULN) logo is displayed on a smartphone screen" width="300" height="169"><div>Source: rafapress / Shutterstock.com</div></div>
Mullen Automotive (NASDAQ:<a href="https://investorplace.com/stock-quotes/muln-stock-quote/">MULN</a>) is the first of a group of electric vehicle stocks that have an &ldquo;F&rdquo; rating on this list. Mullen keeps claiming it&rsquo;s on the verge of putting together something meaningful and puts out statements announcing partnerships and moves to draw investor attention.
But as I wrote a few days ago, it&rsquo;s time to <a href="https://investorplace.com/market360/2023/06/alert-abandon-all-hope-for-muln-stock/" target="_blank">abandon hope for MULN stock</a>, which appears to be on the way to zero.
It doesn&rsquo;t have that far to go to get there. Mullen is down to less than 12 cents per share. They removed it from the Russell 2000 index&nbsp;and it seems destined to be yanked from the Nasdaq composite as well.
Meanwhile, the company continues to dilute its shares, announcing on June 26 a resale of up to 2.33 billion shares.
Mullen did a 1-for-25 stock split in May and now is pitching to shareholders another split that could be as great as 1-for-100.
Whether that keeps Mullen on the Nasdaq is irrelevant at this point. MULN stock has a well-deserved &ldquo;F&rdquo; grade in the Portfolio Grader and is prime among the stocks to sell while you can.

<h2>Workhorse (WKHS)</h2>
<div><img src="https://investorplace.com/wp-content/uploads/2020/09/wkhs_1600_b_workhorse-300x169.jpg" alt="Image of a Workhorse (WKHS) logo and drone on the side of a truck." width="300" height="169"><div>Source: Photo from WorkHorse.com</div></div>
Workhorse (NASDAQ:<a href="https://investorplace.com/stock-quotes/wkhs-stock-quote/">WKHS</a>) was had the inside track on a lucrative government contract. The U.S. Postal Service was looking to buy a new fleet of mail trucks, and Workhorse&rsquo;s EV solutions seemed an obvious choice.
But it wasn&rsquo;t meant to be. The Postal Service <a href="https://time.com/6242616/us-postal-service-trucks-going-electric/">instead picked a defense contractor</a>, Oshkosh (NYSE:<a href="https://investorplace.com/stock-quotes/osk-stock-quote/">OSK</a>), for the work. The contract includes 60,000 vehicles, of which 45,000 will be EVs.
Losing the contract was devastating for Workhorse, which even sued to stop the deal before <a href="https://www.theverge.com/2021/9/15/22675630/workhorse-usps-mail-truck-bid-protest-dropped-oshkosh">abruptly withdrawing its claim</a> in 2021. But it was too late for WKHS stock, which fell nearly 80% in just a few weeks.
Today, the market values Workhorse stock at less than $1 and is in danger of falling out of Nasdaq compliance. It&rsquo;s <a href="https://investorplace.com/2023/06/wkhs-stock-alert-workhorse-just-announced-2-big-milestones/">still trying to put together deals</a>, but the bloom is undoubtedly off this rose.
WKHS stock has an &ldquo;F&rdquo; rating in the Portfolio Grader.

<h2>Lordstown Motors (RIDE)</h2>
<div><img src="https://investorplace.com/wp-content/uploads/2023/02/ride1600-2-300x169.png" alt="Person holding smartphone with logo of US automotive company Lordstown Motors Corporation (RIDE) on screen in front of website. Focus on phone display. Unmodified photo." width="300" height="169"><div>Source: T. Schneider / Shutterstock.com</div></div>
Perhaps no EV stock has had a fall quite like Lordstown Motors (NASDAQ:<a href="https://investorplace.com/stock-quotes/ride-stock-quote/">RIDE</a>). A few years ago, the Ohio company was hailed as a savior of midwestern jobs for its plans to produce EV pickup trucks.
But the company struggled to get off the ground and only sold a few pickups. It <a href="https://www.nytimes.com/2023/06/27/business/lordstown-motors-bankruptcy-foxconn.html">filed for Chapter 11 bankruptcy protection</a> in June and probably will sell off its assets, including the technology and intellectual property for its Endurance pickup truck.
The bankruptcy follows a major falling out with primary investor Hon Hai Precision Industry (OTCMKTS:<a href="https://investorplace.com/stock-quotes/hnhpf-stock-quote/">HNHPF</a>), also known as Foxconn. Lordstown says that Foxconn didn&rsquo;t live up to its investment commitments and did &ldquo;material damage&rdquo; to the company.
Foxconn says that Lordstown breached its agreement by allowing the stock to fall below $1.
Either way, the Lordstown ride is over. The company will be <a href="https://investorplace.com/2023/06/dear-ride-stock-investors-mark-your-calendars-for-july-7/">delisted</a> from the Nasdaq exchange on July 7.
RIDE stock has an &ldquo;F&rdquo; rating in the Portfolio Grader.

<h2>Lumen Technologies (LUMN)</h2>
<div><img src="https://investorplace.com/wp-content/uploads/2021/07/lumn-stock-1-300x169.jpg" alt="A magnifying glass zooms in on the website for Lumen Technologies (LUMN)." width="300" height="169"><div>Source: Postmodern Studio / Shutterstock.com</div></div>
Other industries besides EVs have F-rated stocks to sell, of course. One of those stocks is Lumen Technologies (NYSE:<a href="https://investorplace.com/stock-quotes/lumn-stock-quote/">LUMN</a>), a telecommunications company that provides network services, cloud solutions, voice and managed services.
But Lumen is having a terrible year. The stock is down 57% and notably lost its coveted place in the S&amp;P 500 in March. Now it&rsquo;s part of the S&amp;P SmallCap 600, which isn&rsquo;t nearly as prestigious and has less trading volume.
The Federal Reserve&rsquo;s frequent interest rate hikes have also challenged Lumen. Lumen carries significant debt ($20.2 billion versus only 1.1 billion in cash) so interest rate increases hurt Lumen&rsquo;s bottom line and make the stock much less appealing.
Earnings in the first quarter included revenue of $3.74 billion, down 20% from a year ago. That&rsquo;s trending in the wrong direction, another reason LUMN stock has an &ldquo;F&rdquo; rating in the Portfolio Grader.

<h2>Solid Power (SLDP)</h2>
<div><img src="https://investorplace.com/wp-content/uploads/2022/03/sldp_solid_power_1600-300x169.png" alt="Smartphone with logo of American battery company Solid Power Inc. on screen in front of business website. Focus on center-left of phone display." width="300" height="169"><div>Source: T. Schneider / Shutterstock.com</div></div>
Colorado-based Solid Power (NASDAQ:<a href="https://investorplace.com/stock-quotes/sldp-stock-quote/">SLDP</a>) is an energy storage company specializing in solid-state batteries. Solid-state batteries use solid-state electrolytes instead of liquid or gel electrolytes used in lithium batteries.
The company is hoping to make waves in the EV space, betting that its batteries will be superior to lithium batteries by providing a greater charge and would be less prone to leaks.
But the technology is still unproven, which is why lithium batteries are still in so much demand. While it&rsquo;s possible that Solid Power may one day take off, I have no expectations that it will happen in the second half of 2023.
The company missed modest revenue expectations in the first quarter, bringing in only $3.79 million, while analysts expected $4.03 million. SLDP stock has an &ldquo;F&rdquo; rating in the Portfolio Grader.

<h2>Hycroft Mining (HYMC)</h2>
<div><img src="https://investorplace.com/wp-content/uploads/2022/06/hymc-1600-300x169.png" alt="Hycroft mining facility in Nevada. HYMC stock." width="300" height="169"><div>Source: Elizabeth A.Cummings / Shutterstock</div></div>
Not so long ago, <a href="https://investorplace.com/market360/2023/01/7-micro-cap-stocks-to-buy-for-risk-taking-investors/">I suggested</a> that if you&rsquo;re an investor who wants to take a risk, consider&nbsp;Hycroft Mining (NASDAQ:<a href="https://investorplace.com/stock-quotes/hymc-stock-quote/">HYMC</a>). The Denver-based exploration-stage gold and silver mining company is sitting on 9.6 million ounces of gold reserves and nearly 446 million ounces of silver reserves. You would think that there&rsquo;s money to be made.
But Hycroft is a lot risker today than it was in January. The company&rsquo;s not making any headway, and the stock price is falling fast, from 62 cents per share in January to 29 cents today.
Hycroft got some attention from meme stock traders when AMC Entertainment (NYSE:<a href="https://investorplace.com/stock-quotes/amc-stock-quote/">AMC</a>) unexpectedly took a 22% stake in the company. But that was also a gamble, and it doesn&rsquo;t seem to be paying off for AMC, either.
Earnings in the first quarter for Hycroft included no revenue and expenses of $13.91 million. The company has $132 million in cash and roughly $137 million in debt, and is facing a <a href="https://finance.yahoo.com/news/hycroft-granted-180-day-extension-230000907.html">delisting threat</a> from Nasdaq.
The stock has an &ldquo;F&rdquo; rating from the Portfolio Grader.

<h2>Oncorus (ONCR)</h2>
<div><img src="https://investorplace.com/wp-content/uploads/2022/10/droplet-test-tube-biotech-1600-3-300x169.jpg" alt="Photo of test tubes and droplet with purple and reddish-orange sunset visual effect, representing biotech" width="300" height="169"><div>Source: shutterstock.com/Romix Image</div></div>
Biotech company Oncorus (OTCMTKS:<a href="https://investorplace.com/stock-quotes/oncr-stock-quote/">ONCR</a>) develops intravenously administrated RNA medicines for cancer patients.
It&rsquo;s the smallest company on this list. It doesn&rsquo;t trade on the major indices, the stock is barely 3 cents per share and it has a market capitalization of less than $1 million.
There are serious questions about the company&rsquo;s viability. In June, the board approved a plan to lay off the entire workforce of 55 people, including the CEO, COO and chief medical officer. Even with that move, Oncorus announced that it doesn&rsquo;t have cash or projected cash flow to keep the company operating past the third quarter.
&ldquo;The company continues to assess all available strategic options to maximize value for all of its stakeholders, including, but not limited to, an acquisition, merger, reverse merger, divestiture of assets, licensing, or other strategic transactions,&rdquo; it said in a statement. &ldquo;However, there is no set timetable for this process and there can be no assurance that this process will result in the company pursuing a transaction or that any transaction, if pursued, will be completed on attractive terms.&rdquo;
If those avenues fail, Oncorus is looking at bankruptcy or simply winding down operations. Either way, it&rsquo;s not a stock you want to hold in the second half of 2023.
ONCR stock has an &ldquo;F&rdquo; rating in the Portfolio Grader.
On the date of publication, neither Louis&nbsp;Navellier nor the InvestorPlace Research Staff member primarily responsible for this article held (either directly or indirectly) any positions in the securities mentioned in this article.
<div>
Louis Navellier, who has been called &ldquo;one of the most important money managers of our time,&rdquo; has broken the silence in <a href="https://orders.investorplace.com/?cid=MKT499868&amp;eid=MKT529642&amp;encryptedSnaid=&amp;snaid=&amp;step=start">this shocking &ldquo;tell all&rdquo; video</a>&hellip; exposing one of the most shocking events in our country&rsquo;s history&hellip; and <a href="https://orders.investorplace.com/?cid=MKT499868&amp;eid=MKT529642&amp;encryptedSnaid=&amp;snaid=&amp;step=start">the one move every American needs to make today</a>.
</div>
<h3>More From InvestorPlace</h3>
<ul><li>
						<a href="https://investorplace.com/2022/07/little-known-apple-project/?cid=MKT639809&amp;eid=MKT739312">Buy This $5 Stock BEFORE This Apple Project Goes Live</a>
					</li>
<li>
						<a href="https://investorplace.com/2023/05/did-elon-musk-just-trigger-a-new-netscape-moment/?cid=MKT738510&amp;eid=MKT741575">Did Elon Musk Just Trigger a New Netscape Moment?</a>
					</li>
<li>
						<a href="https://investorplace.com/2022/06/this-could-be-the-best-deal-in-the-history-of-independent-investing-research/?cid=MKT638063&amp;eid=MKT739344">The $1 Investment You MUST Take Advantage of Right Now</a>
					</li>
<li>
						<a href="https://investorplace.com/2023/05/secret-income-blueprint-of-the-one-percent/?cid=MKT730394&amp;eid=MKT738955">The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors</a>
					</li>
</ul><div>
<div>
<div></div>
<div></div>
</div>
</div>

The post <a href="https://investorplace.com/market360/2023/07/7-f-rated-stocks-to-sell-for-the-second-half-of-2023/">7 F-Rated Stocks to Sell for the Second Half of 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.